TOKYO -- Fujifilm continues to call itself a photographic filmmaker, but the Tokyo-based company sees its future in the health care business.
Drug trial in China highlights company's industrial transformation through M&A

Under CEO Shigetaka Komori, Fujifilm has transformed itself through dealmaking. (Photo by Akira Kodaka)
TOKYO -- Fujifilm continues to call itself a photographic filmmaker, but the Tokyo-based company sees its future in the health care business.